Condividi contenuti The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Aggiornato: 20 min 8 sec fa

Teleflex Awarded HealthTrust Agreement for Peripherally Inserted Central Catheter (PICC) Products

Mar, 01/13/2015 - 13:02
WAYNE, Pa.--(Healthcare Sales & Marketing Network)--Teleflex Incorporated (TFX), a leading global provider of medical devices for critical care and surgery, has announced a new agreement with HealthTrust covering PICC (peripherally inserted central cathete...
Devices, Group Purchasing
Teleflex, HealthTrust, ARROW, PICC

ContraVir Pharmaceuticals Appoints John Sullivan-Bolyai, M.D., MPH, as Chief Medical Officer

Mar, 01/13/2015 - 12:58
EDISON, N.J., Jan. 13, 2015 -- (Healthcare Sales & Marketing Network) -- ContraVir Pharmaceuticals, Inc. (CTRV), a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced today the appointment ...
Biopharmaceuticals, Personnel
ContraVir Pharmaceuticals

MannKind CEO Alfred Mann to Transition to Executive Chairman; COO and President Hakan Edstrom Appointed to CEO

Lun, 01/12/2015 - 16:59
Alfred Mann to Remain Focused on Development and Financing of Future Products of MannKind VALENCIA, Calif., Jan. 12, 2015 -- (Healthcare Sales & Marketing Network) -- MannKind Corporation (MNKD), a biopharmaceutical-based technology company, today annou...
Biopharmaceuticals, Personnel
MannKind

Debiopharm Group(TM) Regains Full Rights to Alisporivir Program

Lun, 01/12/2015 - 12:44
Novartis returns Alisporivir (DEB025) to Debiopharm Group™ including all rights for HCV and other indications LAUSANNE, Switzerland, January 12, 2015 -- (Healthcare Sales & Marketing Network) -- Debiopharm Group™ (Debiopharm), a Swiss-based global biop...
Biopharmaceuticals
Debiopharm Group, Novartis, Alisporivir, Hepatitis C

CTI BioPharma Appoints Alan K. Burnett, M.D. As Therapeutic Area Lead, Myeloid Diseases

Lun, 01/12/2015 - 12:39
SEATTLE, Jan. 12, 2015 -- (Healthcare Sales & Marketing Network) -- CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) announced today the appointment of Alan K. Burnett, M.D., to serve as the strategic leader for myeloid development. Dr. Burnett ...
Biopharmaceuticals, Personnel
CTI BioPharma Corp

Micro Interventional Devices, Inc. Completes STASIS Clinical Trial Enrollment

Ven, 01/09/2015 - 21:16
Permaseal meets primary clinical endpoints NEWTOWN, Pa., Jan. 9, 2015 -- (Healthcare Sales & Marketing Network) -- Micro Interventional Devices, Inc. (MID) has completed enrollment in its Secure Transapical Access and Closure Study (STASIS). STASIS is...
Devices, Interventional Cardiology
Micro Interventional Devices, Permaseal, transcatheter, valve replacement

bioTheranostics Appoints Key Executives to Leadership Team

Ven, 01/09/2015 - 21:06
SAN DIEGO--(Healthcare Sales & Marketing Network)--bioTheranostics, Inc., a leader in molecular diagnostics for cancer, today announced the addition of two industry veterans to its senior management team as the company focuses on further commercial expansi...
Diagnostics, Personalized Medicine, Oncology, Personnel
bioTheranostics, Breast Cancer Index

Endo Announces Changes to Senior Management Team

Ven, 01/09/2015 - 21:01
Moves designed to accelerate Endo's continued evolution into a leading global specialty healthcare company Changes to reporting structure will support Endo's future growth DUBLIN, Jan. 9, 2015 -- (Healthcare Sales & Marketing Network) -- Endo Intern...
Biopharmaceuticals, Personnel
Endo International

Kite Pharma Expands Senior Management Team With Appointment of Claudine Prowse, Ph.D., as SVP, Corporate Communications and Investor Relations

Ven, 01/09/2015 - 20:56
SANTA MONICA, Calif., Jan. 9, 2015 -- (Healthcare Sales & Marketing Network) -- Kite Pharma, Inc., (KITE), a clinical-stage biopharmaceutical company focused on developing engineered autologous T cell therapy (eACT(TM)) products for the treatment of cancer...
Biopharmaceuticals, Oncology, Personnel
Kite Pharma, immunotherapy, chimeric antigen receptor

Straub Medical AG obtains approval for Rotarex(R)S and Aspirex(R)S endovascular catheters in China

Gio, 01/08/2015 - 13:32
Chinese FDA approves Straub Endovascular System Wangs, Switzerland, (Healthcare Sales & Marketing Network) - Straub Medical AG announced today that the Chinese FDA has approved the Straub Endovascular System with its Rotarex®S and Aspirex®S rota...
Devices, Interventional, Regulatory
Straub Medical AG, Straub Endovascular, RotarexS, AspirexS, rotational catheters

Vascular Dynamics Inc. Secures $16.85 Million Series B Financing

Gio, 01/08/2015 - 13:17
The Funding Will Be Used to Advance the Company's Program for the Treatment of Resistant Hypertension MOUNTAIN VIEW, CA--(Healthcare Sales & Marketing Network) - Vascular Dynamics Inc. (VDI) a medical device company providing minimally invasive solution...
Devices, Venture Capital
Vascular Dynamics, resistant hypertension, MobiusHD, CALM-FIM

Myriad Obtains CE Mark for Tumor BRACAnalysis CDx(TM) and Launches Test in Europe as Companion Diagnostic for PARP Inhibitors

Gio, 01/08/2015 - 13:06
Identifies Up to 44 Percent More Eligible Patients Than Conventional BRCA Tests SALT LAKE CITY and ZURICH, Jan. 8, 2015 -- (Healthcare Sales & Marketing Network) -- Myriad Genetics, Inc. (MYGN) today announced the Company has obtained CE Marking in Euro...
Diagnostics, Oncology, Regulatory
Myriad Genetics, BRACAnalysis CDx, BRCA1, BRCA2, Lynparza, PARP

Philips receives FDA 510(k) clearance for its latest Avalon CL Fetal Monitoring solution

Mer, 01/07/2015 - 13:14
Advanced cableless solution detects fetal heart rate and maternal pulse allowing beneficial freedom of movement during labor ANDOVER, Mass., Jan. 7, 2015 -- (Healthcare Sales & Marketing Network) -- Royal Philips (NYSE: PHG AEX: PHIA) today announced ...
Devices, Monitoring, FDA
Royal Philips, Avalon CL, Fetal Monitoring

Blend Therapeutics Secures $21 Million Financing and Unveils Novel Pentarin(TM) Platform for Cancer Therapeutics

Mer, 01/07/2015 - 13:07
Company’s Technology and Expertise in Cancer R&D Evolve to Create New Class of Miniaturized Biologic Drug Conjugates (mBDCs) Encapsulated in Nanoparticles WATERTOWN, Mass.--(Healthcare Sales & Marketing Network)--Blend Therapeutics, Inc., a biopharmaceu...
Biopharmaceuticals, Oncology, Venture Capital
Blend Therapeutics, Pentarin , miniaturized biologic drug conjugates

AVEO Announces Executive Transition and Corporate Restructuring

Mer, 01/07/2015 - 13:01
Michael P. Bailey Named President and Chief Executive Officer; Tuan Ha-Ngoc Named Chairman of the Board Company to Eliminate Internal Research Function to Align Corporate Resources with the Company’s Future Strategic Plans CAMBRIDGE, Mass.--(Healthc...
Biopharmaceuticals, Oncology, Personnel
AVEO Oncology

Mundipharma receives positive European Commission decision on Targin(R) (oxycodone/naloxone) for the treatment of Restless Legs Syndrome1

Mer, 01/07/2015 - 12:53
CAMBRIDGE, England--(Healthcare Sales & Marketing Network)--Mundipharma today announced that Targin® (Targinact®, Targiniq®), a fixed combination of prolonged-release oxycodone/naloxone, has received a positive European Commission decision for ...
Biopharmaceuticals, Regulatory
Mundipharma, Targin, Targinact, Targiniq, restless legs syndrome

CytomX Raises $20 Million in Series C Round Led by Pfizer Venture Investments

Mar, 01/06/2015 - 13:05
Financing will help support advancement of Probody therapeutics towards the clinic SOUTH SAN FRANCISCO, Calif., Jan. 6, 2015 -- (Healthcare Sales & Marketing Network) -- CytomX, a biotechnology company developing Probody™ therapeutics for the treatment...
Biopharmaceuticals, Oncology, Venture Capital
CytomX Therapeutics, Probody

Isis Pharmaceuticals Appoints Paula Soteropoulos As President And Chief Executive Officer Of Akcea Therapeutics

Mar, 01/06/2015 - 13:00
Isis-owned Subsidiary Launched to Conduct Development and Commercialization of Isis' Lipid Franchise Drugs CARLSBAD, Calif. and CAMBRIDGE, Mass., Jan. 6, 2015 -- (Healthcare Sales & Marketing Network) -- Isis Pharmaceuticals, Inc. (ISIS) announced toda...
Biopharmaceuticals, Personnel
Isis Pharmaceuticals, Akcea Therapeutics

Cohera Medical, Inc.(R) Receives PMA Approvable Letter from U.S. FDA for TissuGlu(R) Surgical Adhesive

Mar, 01/06/2015 - 12:53
Cohera CEO to present on latest Company updates at 33rd Annual J.P. Morgan Healthcare Conference PITTSBURGH, Jan. 6, 2015 -- (Healthcare Sales & Marketing Network) -- Cohera Medical, Inc.®, a leading innovator and developer of absorbable surgical a...
Devices, FDA
Cohera Medical, surgical adhesive, TissuGlu

CytRx Announces Positive Interim Phase 2 Aldoxorubicin Results in Glioblastoma Multiforme (Brain Cancer)

Mar, 01/06/2015 - 12:46
Aldoxorubicin Shows a Complete Response, Tumor Shrinkage, Prolonged Stable Disease, and Favorable Tolerability in Patients Novel Albumin-Binding Drug Candidate Appears to Allow Doxorubicin to Cross the Tumor's Blood-Brain Barrier in Humans LOS ANGELE...
Biopharmaceuticals, Oncology
CytRx, aldoxorubicin, glioblastoma multiforme, brain cancer

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong